维普中文期刊产品整合服务
27篇 您的检索式:作者名="Alimena"
    题名 作者 年代 出处 被引量
1The long-term dura- bility of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up 显示文摘Palandri F Castagnetti F Alimena G 2009Haematologica2009,94,2:1
2Cytogenetic pattern in leukemia cells of patients with constitutional chromosome anomalies 显示文摘Alimena G Billstrom R Casalone R 1985Cancer Genet Cytogenet1985,16,3:1
3Correlation of occupation and karyotype in adult with acute nonlymphocytic leukemia显示文摘Golomb HM Alimena G Rowley JD 1982Blood1982,60,2:1
4Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorized as unclassified (MDS/MPD-U) by WHO classification显示文摘Laura Cannella Massimo Breccia Roberto Latagliata Annamaria Frustaci Giuliana Alimena 2007Leukemia Research2007,,3:1
5Nilotinib: a second-generation tyrosine kinase inhibitor for chronic myeloid leukemia显示文摘BRECCIA M ALIMENA G 2010Leuk Res2010,34,2:1
6Long-term survival in acute myelogenous leukemia, a second follow-up of the fourth international workshop on chromosomes in leukemia显示文摘Swansbury GT Lawler SD Alimena G 1994Cancer Genet Cytogenet1994,73,1:1
7NF-KB as a potential therapeutic target in myelodysplastic syndromes and acute myeloid leukemia 显示文摘Breccia M Alimena G 2010Expert Opin Ther Targets2010,14,11:1
8Nilotinib: A second-gen- eration tyrosine kinase inhibitor for chronic myeloid leukemia显示文摘BRECCIA M ALIMENA G 2010Leukemia Research2010,34,:1
9Nilotinib : a second-generationtyrosine kinase inhibitor for chronic myeloid leukemia 显示文摘BRECCIA M ALIMENA G 2010Leuk Res2010,34,2:1
10The long-term durability of eytogenetic responses in patients with accel- erated phase chronic myeloid leukemia treated with ima- tinib 600 mg:the GIMEMA CML Working Party experi- ence after a 7-year follow-up显示文摘Palandri F Castagnetti F Alimena G 2009Haematologica2009,94,2:1
11A collaborative study ofthe relationship of the morphologyic type of acute nonlymphocyticleukemia with patient age and karyotype显示文摘Rowley JD Alimena G Carson OM 1982Blood1982,59,5:1
12Imatinib treatment in chronic myelogenous leukemia: What have we learned so far? 显示文摘BRECCIA M EFFICACE F ALIMENA G 2011CancerLett2011,300,2:1
13Quality of life in elderly patients with acute myeloid leukemia:patients may be more accurate than physicians 显示文摘Oliva EN Nobile F Alimena G 2011Haematologica2011,96,5:1
14Long-term survival in acute myelogenous leukemia: A second follow-up of the Fourh International Workshop on chromosome in leukemia 显示文摘Swansburg G T Lawler S D Alimena G 1994Cancer Genet Cytogenet1994,73,:1
15Nilotinib:a second-generation tyrosine kinase inhibitor for chronic myeloid leukemia显示文摘Breccia M Alimena G 2010Leuk Res2010,34,2:1
16Nilotinib:a second-generation tyrosine ki-nase inhibitor for chronic myeloid leukemia显示文摘Breccia M Alimena G 2010Leuk Res2010,34,2:1
17Tetraploid KaryoPe in two patients with acute lymphoblastic leukemia 显示文摘Helm S Alimena G Billstrom R 1987Cancer Genet Cytogenet1987,29,:1
18Nilotinib: a second - generation tyrosine kinase in- hibitor for chronic myeloid leukemia 显示文摘Breccia M Alimena G 2010Leuk Res2010,34,2:1
19Dasatinib in the management of lymphoid blast crisis of Philadelphia-positive chronic myeloid leukemia with multiple extra-medullary and intracranial localizations显示文摘Giuliana Alimena Massimo Breccia Roberto Latagliata Sara Grammatico Angela Matturro Saveria Capria Maria Stefania De Propris Daniela Diverio Giovanna Meloni 2009Leukemia Research2009,,8:1
20Unusual derma- tologic toxicity of long-term therapy with hydroxyurea in chnnie myelogenous leukemia显示文摘Montefusco E Alimena G Gastaldi R 1986Tumori1986,72,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费